[
  {
    "ts": "2025-11-05T04:31:04+00:00",
    "headline": "Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts",
    "summary": "A new regulatory filing shows that billionaire investor Michael Burry's hedge fund Scion Asset Management purchased five million put options on Palantir Technologies, Inc. (NASDAQ:PLTR) and one million put options on NVIDIA Corp. (NASDAQ:NVDA), among ...",
    "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "0c1283d4-df14-3ee2-9d0a-6d5623cb5e0c",
      "content": {
        "id": "0c1283d4-df14-3ee2-9d0a-6d5623cb5e0c",
        "contentType": "STORY",
        "title": "Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts",
        "description": "",
        "summary": "A new regulatory filing shows that billionaire investor Michael Burry's hedge fund Scion Asset Management purchased five million put options on Palantir Technologies, Inc. (NASDAQ:PLTR) and one million put options on NVIDIA Corp. (NASDAQ:NVDA), among ...",
        "pubDate": "2025-11-05T04:31:04Z",
        "displayTime": "2025-11-05T04:31:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce",
          "originalWidth": 720,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TTciiphdQR88uNeAEBOPyA--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce.cf.webp",
              "width": 720,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pQuyOpoLC5jVJ3Eq2VY_ZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "https://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "LULU"
            },
            {
              "symbol": "SLM"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "EL"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "MELI"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "HAL"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "MOH"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "IDLE-USD"
            },
            {
              "symbol": "OPAI.PVT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T15:48:00+00:00",
    "headline": "Ultragenyx Q3 Earnings and Sales Miss Estimates, Increase Y/Y",
    "summary": "RARE's Q3 loss widens and revenues miss estimates, despite year-over-year sales growth of key rare disease drugs.",
    "url": "https://finance.yahoo.com/news/ultragenyx-q3-earnings-sales-miss-154800315.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "392cc98f-757e-3f0a-8752-3e61aeeebccb",
      "content": {
        "id": "392cc98f-757e-3f0a-8752-3e61aeeebccb",
        "contentType": "STORY",
        "title": "Ultragenyx Q3 Earnings and Sales Miss Estimates, Increase Y/Y",
        "description": "",
        "summary": "RARE's Q3 loss widens and revenues miss estimates, despite year-over-year sales growth of key rare disease drugs.",
        "pubDate": "2025-11-05T15:48:00Z",
        "displayTime": "2025-11-05T15:48:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzN04L.MG5n2SiOn76bXjg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1EIdoTL1xBchT1nrSboC2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ultragenyx-q3-earnings-sales-miss-154800315.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ultragenyx-q3-earnings-sales-miss-154800315.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RARE"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T18:18:37+00:00",
    "headline": "Assessing Regeneron After New Drug Pipeline Expansions and Double-Digit Share Price Decline",
    "summary": "Wondering if Regeneron Pharmaceuticals is a hidden gem or just fairly priced? You are not alone; investors everywhere are asking whether now is the right moment to jump in or sit on the sidelines. The stock's journey lately has been anything but dull. It saw a 4.7% rise over the past month after sliding 4.0% in the last week, while the shares remain down 24.0% over the past year. Recent headlines have highlighted Regeneron's expanding drug pipeline and ongoing innovations in treating rare...",
    "url": "https://finance.yahoo.com/news/assessing-regeneron-drug-pipeline-expansions-181837370.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "e3707156-03ff-35e8-9c52-1eac854634c3",
      "content": {
        "id": "e3707156-03ff-35e8-9c52-1eac854634c3",
        "contentType": "STORY",
        "title": "Assessing Regeneron After New Drug Pipeline Expansions and Double-Digit Share Price Decline",
        "description": "",
        "summary": "Wondering if Regeneron Pharmaceuticals is a hidden gem or just fairly priced? You are not alone; investors everywhere are asking whether now is the right moment to jump in or sit on the sidelines. The stock's journey lately has been anything but dull. It saw a 4.7% rise over the past month after sliding 4.0% in the last week, while the shares remain down 24.0% over the past year. Recent headlines have highlighted Regeneron's expanding drug pipeline and ongoing innovations in treating rare...",
        "pubDate": "2025-11-05T18:18:37Z",
        "displayTime": "2025-11-05T18:18:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w30LARiR1Z35GusfaFi.2g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3eDp_RSETU8kXm3usDK_gQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-regeneron-drug-pipeline-expansions-181837370.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-regeneron-drug-pipeline-expansions-181837370.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]